Acurx Pharmaceuticals prices $15M IPO (NASDAQ:ACXP)

Clinical stage biopharmaceutical company Acurx Pharmaceuticals (ACXP) has priced its IPO of 2.5M newly-issued common shares at $6.00/share, for expected gross proceeds of…
Read More